These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9231990)

  • 1. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
    Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
    Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
    Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum intercellular adhesion molecule ICAM-1 concentration in interferon alpha treated patients with chronic viral C hepatitis].
    Warakomska I; Wiczkowski A; Kepa L; Stolarz W; Wilczek K; Błedowski D; Sobala-Szczygieł B; Oczko-Grzesik B; Dziambor AP; Mossor K
    Wiad Lek; 2004; 57(11-12):641-6. PubMed ID: 15865242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of interferon on hepatic intercellular adhesion molecule-1 expression in patients with chronic hepatitis B].
    Zheng RD; Xu CR; Zhang MF; Meng JR; Rao RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):878-9. PubMed ID: 18504225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary results of the treatment of patients with chronic active hepatitis (CAH) HBsAg+,HBeAg+ with low oral doses of human interferon-alpha].
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz J; Cummins J; Georgiades J
    Przegl Epidemiol; 1991; 45(4):325-30. PubMed ID: 1841411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
    Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
    Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis.
    Yang SS; Tsai G; Wu CH; Chen DS
    Hepatogastroenterology; 1996; 43(9):575-81. PubMed ID: 8799398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids.
    Hoffmann JC; Dengler TJ; Knolle PA; Albert-Wolf M; Roux M; Wallich R; Meuer SC
    Eur J Immunol; 1993 Nov; 23(11):3003-10. PubMed ID: 7693485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
    Molica S; Levato D; Dell' Olio M; Cascavilla N; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1997; 82(2):148-51. PubMed ID: 9175316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
    Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
    Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of interferon-alpha therapy for HBeAg-negative chronic hepatitis B and its influencing factors].
    Mao QG; Luo KX; Fu QF; Feng XR; Guo YB; Zhu YF; Peng J; Hou JJ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):582-4. PubMed ID: 15504285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
    Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm SW
    Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.